3.89
price up icon8.36%   0.30
pre-market  Pre-market:  3.96   0.07   +1.80%
loading
Precigen Inc stock is traded at $3.89, with a volume of 9.29M. It is up +8.36% in the last 24 hours and up +32.31% over the past month. Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
See More
Previous Close:
$3.59
Open:
$3.63
24h Volume:
9.29M
Relative Volume:
1.21
Market Cap:
$1.16B
Revenue:
$6.23M
Net Income/Loss:
$-95.90M
P/E Ratio:
-9.9744
EPS:
-0.39
Net Cash Flow:
$-68.47M
1W Performance:
-5.81%
1M Performance:
+32.31%
6M Performance:
+116.11%
1Y Performance:
+289.08%
1-Day Range:
Value
$3.60
$4.14
1-Week Range:
Value
$3.47
$4.21
52-Week Range:
Value
$0.6513
$5.225

Precigen Inc Stock (PGEN) Company Profile

Name
Name
Precigen Inc
Name
Phone
301-556-9900
Name
Address
20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD
Name
Employee
25
Name
Twitter
@precigen
Name
Next Earnings Date
2025-03-19
Name
Latest SEC Filings
Name
PGEN's Discussions on Twitter

Compare PGEN with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
PGEN
Precigen Inc
3.89 1.07B 6.23M -95.90M -68.47M -0.39
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
391.36 100.82B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
461.24 60.45B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
575.06 60.69B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
752.32 46.32B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
327.20 36.58B 3.81B -644.79M -669.77M -6.24

Precigen Inc Stock (PGEN) Upgrades & Downgrades

Date Action Analyst Rating Change
Aug-15-25 Upgrade JP Morgan Underweight → Neutral
Mar-22-24 Downgrade JP Morgan Neutral → Underweight
May-23-23 Initiated JP Morgan Neutral
Nov-18-22 Initiated Cantor Fitzgerald Overweight
Feb-25-21 Initiated Stifel Buy
Feb-22-21 Initiated Wells Fargo Overweight
Feb-18-21 Initiated B. Riley Securities Buy
May-08-20 Initiated H.C. Wainwright Buy
View All

Precigen Inc Stock (PGEN) Latest News

pulisher
Sep 16, 2025

Precigen (PGEN) Secures FDA Approval for Papillomatosis Treatment - MSN

Sep 16, 2025
pulisher
Sep 16, 2025

Growth Value: Is Precigen Inc. exposed to political riskJuly 2025 Trade Ideas & Weekly Breakout Opportunity Watchlist - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Is Precigen Stock Ready For Takeoff? - StocksToTrade

Sep 16, 2025
pulisher
Sep 16, 2025

Resistance Check: Will Precigen Inc stock go up in YEARWeekly Trading Summary & Risk Adjusted Buy/Sell Alerts - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Ideas Watch: Will Precigen Inc stock go up in YEAREarnings Summary Report & Daily Market Momentum Tracking - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

235,112 Shares in Precigen, Inc. $PGEN Acquired by Inspire Investing LLC - MarketBeat

Sep 16, 2025
pulisher
Sep 15, 2025

Precigen announces up to $125M non-dilutive financing - MSN

Sep 15, 2025
pulisher
Sep 15, 2025

Precigen Signs a Credit Facility Agreement Worth $125 Million to Support PAPZIMEOS - Yahoo Finance

Sep 15, 2025
pulisher
Sep 15, 2025

Precigen, Inc. (NASDAQ:PGEN) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Sep 15, 2025
pulisher
Sep 14, 2025

MetLife Investment Management LLC Purchases New Position in Precigen, Inc. $PGEN - MarketBeat

Sep 14, 2025
pulisher
Sep 14, 2025

Precigen Stock Tumbles as Company Undertakes Massive Shares Sale - StocksToTrade

Sep 14, 2025
pulisher
Sep 14, 2025

Precigen (NASDAQ:PGEN) Trading Down 3.7%Should You Sell? - MarketBeat

Sep 14, 2025
pulisher
Sep 13, 2025

Could Precigen's (PGEN) New Credit Facility Reshape Its Approach to Shareholder Dilution? - simplywall.st

Sep 13, 2025
pulisher
Sep 12, 2025

These 2 Healthcare Stocks More Than Doubled Recently and Could Soar Higher, According to Wall Street Analysts - MSN

Sep 12, 2025
pulisher
Sep 12, 2025

4 years from clinic to approval — Precigen’s ‘unprecedented’ FDA nod and what comes next - PharmaVoice

Sep 12, 2025
pulisher
Sep 12, 2025

EVERSANA Named by Precigen for U.S. Commercialization of PAPZIMEOS - Eastern Progress

Sep 12, 2025
pulisher
Sep 11, 2025

Adage Capital Partners GP L.L.C. Boosts Holdings in Precigen, Inc. $PGEN - MarketBeat

Sep 11, 2025
pulisher
Sep 11, 2025

Nuveen LLC Makes New Investment in Precigen, Inc. $PGEN - MarketBeat

Sep 11, 2025
pulisher
Sep 11, 2025

Precigen’s (PGEN) Papzimeos Push Sparks Multibagger Ascent, Boosted by Analyst Optimism - Yahoo Finance

Sep 11, 2025
pulisher
Sep 10, 2025

Parkman Healthcare Partners LLC Invests $4.76 Million in Precigen, Inc. $PGEN - MarketBeat

Sep 10, 2025
pulisher
Sep 09, 2025

Recurrent Respiratory Papillomatosis Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Observes | Precigen, Inovio Pharma - Barchart.com

Sep 09, 2025
pulisher
Sep 08, 2025

Precigen Inc. Approaches Support With Recovery in SightJuly 2025 Trade Ideas & Weekly Top Gainers Alerts - beatles.ru

Sep 08, 2025
pulisher
Sep 08, 2025

Precigen (NASDAQ:PGEN) Sets New 12-Month HighShould You Buy? - MarketBeat

Sep 08, 2025
pulisher
Sep 08, 2025

Will Precigen Inc. stock go up in YEARGlobal Markets & Weekly High Return Opportunities - 뉴스영

Sep 08, 2025
pulisher
Sep 07, 2025

These 2 Healthcare Stocks More Than Doubled Recently and Could Soar Higher, According to Wall Street Analysts - The Motley Fool

Sep 07, 2025
pulisher
Sep 07, 2025

Precigen (NASDAQ:PGEN) Trading 7.8% HigherStill a Buy? - MarketBeat

Sep 07, 2025
pulisher
Sep 06, 2025

Precigen Inc. Rebounds From Oversold Zone — Now WhatWeekly Market Summary & Fast Gain Stock Tips - beatles.ru

Sep 06, 2025
pulisher
Sep 06, 2025

Visual trend scoring systems applied to Precigen Inc.2025 Trading Recap & Consistent Growth Stock Picks - Newser

Sep 06, 2025
pulisher
Sep 06, 2025

PGEN: JMP Securities Raises Price Target, Maintains Rating | PGE - GuruFocus

Sep 06, 2025
pulisher
Sep 06, 2025

Should you wait for a breakout in Precigen Inc.July 2025 Intraday Action & Long-Term Safe Investment Plans - Newser

Sep 06, 2025
pulisher
Sep 06, 2025

Is Precigen Inc. a top pick in the sectorRecession Risk & AI Powered Market Entry Ideas - خودرو بانک

Sep 06, 2025
pulisher
Sep 06, 2025

Is Precigen Inc. stock good for income investorsJuly 2025 Update & Long-Term Safe Investment Ideas - خودرو بانک

Sep 06, 2025
pulisher
Sep 06, 2025

What’s the profit margin of Precigen Inc.2025 Buyback Activity & Consistent Income Trade Ideas - خودرو بانک

Sep 06, 2025
pulisher
Sep 06, 2025

Is Precigen Inc. a play on infrastructure spending2025 EndofYear Setup & Risk Managed Investment Entry Signals - خودرو بانک

Sep 06, 2025
pulisher
Sep 06, 2025

Agee Nancy H, Precigen director, buys $69,000 in shares - Investing.com India

Sep 06, 2025
pulisher
Sep 06, 2025

Agee Nancy H, Precigen director, buys $69,000 in shares By Investing.com - Investing.com Australia

Sep 06, 2025
pulisher
Sep 05, 2025

Nancy Agee Increases Stake in Precigen Inc with Recent Purchase - GuruFocus

Sep 05, 2025
pulisher
Sep 05, 2025

Live market analysis of Precigen Inc.Analyst Downgrade & Entry and Exit Point Strategies - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Candlestick signals on Precigen Inc. stock todayShort Setup & Smart Swing Trading Alerts - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Is Precigen Inc. stock risky to hold nowOptions Play & Weekly Setup with ROI Potential - خودرو بانک

Sep 05, 2025
pulisher
Sep 05, 2025

Is Precigen Inc. stock bottoming outJuly 2025 Macro Moves & Reliable Price Breakout Signals - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Will Precigen Inc. outperform the marketJuly 2025 News Drivers & Expert Verified Stock Movement Alerts - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Charles Schwab Investment Management Inc. Has $1.81 Million Stock Position in Precigen, Inc. $PGEN - MarketBeat

Sep 05, 2025
pulisher
Sep 04, 2025

Is a relief rally coming for Precigen Inc. holdersBear Alert & Community Trade Idea Sharing - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Reversal indicators forming on Precigen Inc. stockIPO Watch & Reliable Breakout Forecasts - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Precigen, Inc. shares rise 1.05% premarket after securing a $125 million credit facility. - AInvest

Sep 04, 2025
pulisher
Sep 04, 2025

Custom watchlist performance reports with Precigen Inc.July 2025 Review & Technical Pattern Alert System - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

How to recover losses in Precigen Inc. stockJuly 2025 Snapshot & Capital Efficient Trading Techniques - Newser

Sep 04, 2025

Precigen Inc Stock (PGEN) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$35.42
price up icon 0.77%
$83.90
price up icon 0.91%
$28.24
price up icon 0.89%
$99.26
price up icon 1.41%
$144.75
price up icon 1.12%
biotechnology ONC
$327.20
price down icon 1.53%
Cap:     |  Volume (24h):